#BEGIN_DRUGCARD DB04439

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C31H53NO22

# Chemical_IUPAC_Name:
(2R,3S,4R,5R,6S)-2-{[(1S,4R,5S,6R)-4-{[(2R,3S,4S,5R,6S)-6-{[(2S,3S,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2S,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]amino}-5,6-dihydroxy-2-(hydroxymethyl)cyclohex-2-en-1-yl]oxy}-6-methyloxane-3,4,5-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Modified Acarbose Pentasaccharide

# HET_ID:
ACG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C31H53NO22/c1-7-13(32-10-3-9(4-33)25(18(40)15(10)37)52-30-23(45)17(39)14(36)8(2)49-30)16(38)22(44)29(48-7)53-27-12(6-35)51-31(24(46)20(27)42)54-26-11(5-34)50-28(47)21(43)19(26)41/h3,7-8,10-47H,4-6H2,1-2H3/t7-,8+,10-,11+,12+,13-,14+,15+,16+,17-,18-,19-,20-,21-,22-,23+,24-,25+,26-,27-,28-,29+,30-,31+/m1/s1

# InChI_Key:
InChIKey=QWNATFSCUHKKDP-KHDASAEXSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4439

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
791.746

# Molecular_Weight_Mono:
791.305922385

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1LWJ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
-0.94

# Predicted_Water_Solubility:
8.99e+01 g/l

# Primary_Accession_No:
DB04439

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936978

# PubChem_Substance_ID:
46508537

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00411

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@@H]1O[C@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](N[C@@H]3[C@@H](C)O[C@@H](O[C@@H]4[C@H](CO)O[C@@H](O[C@@H]5[C@H](CO)O[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)C=C2CO)[C@@H](O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:20 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000512

# Drug_Target_1_GenBank_ID_Protein:
4980866

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
mgtA

# Drug_Target_1_Gene_Sequence:
>1326 bp
ATGATAGGCTATCAGATCTACGTGAGATCTTTCAGGGATGGAAACCTCGACGGTGTGGGA
GATTTCAGGGGATTGAAAAACGCTGTTTCCTACCTGAAAGAACTGGGGATTGACTTTGTC
TGGCTCATGCCTGTTTTTTCCTCCATATCTTTTCACGGGTACGACGTGGTGGATTTTTAT
TCTTTCAAAGCTGAGTACGGTAGTGAGAGAGAGTTCAAAGAGATGATCGAGGCATTCCAC
GACAGCGGAATAAAAGTCGTTCTTGACCTTCCCATCCATCACACAGGCTTTCTCCACACG
TGGTTCCAGAAGGCGCTGAAAGGAGATCCACACTACAGAGATTACTACGTATGGGCAAAC
AAAGAGACGGATCTGGACGAAAGAAGAGAGTGGGATGGAGAAAAGATCTGGCATCCCCTG
GAAGATGGGAGGTTCTACAGAGGGCTCTTTGGACCTTTCTCACCCGACTTGAACTACGAC
AACCCGCAGGTATTCGATGAAATGAAAAGACTGGTTCTCCACCTTCTCGATATGGGAGTG
GATGGTTTCAGGTTCGATGCAGCAAAGCACATGAGAGATACGATCGAACAGAATGTTCGC
TTCTGGAAGTACTTTCTTTCCGATTTGAAGGGCATCTTCCTCGCAGAGATATGGGCAGAG
GCCAGAATGGTGGATGAACACGGCAGAATATTTGGCTACATGCTCAACTTTGACACATCC
CACTGTATAAAGGAAGCTGTATGGAAAGAGAACACAAGAGTTCTGATAGAGTCGATCGAA
AGGGCCGTTATCGGCAAAGACTACCTCCCGGTGAATTTTACTTCGAATCACGACATGTCG
AGGCTTGCAAGCTTTGAAGGAGGCTTCAGCAAAGAAAAGATCAAACTTTCGATTTCCATT
CTTTTCACTCTCCCGGGAGTTCCTCTCGTGTTCTATGGGGATGAGCTTGGAATGAAGGGA
GTTTACCAGAAACCGAACACAGAAGTCGTCCTGGATCCGTTCCCGTGGAACGAGAGTATG
TGCGTTGAGGGACAGACCTTCTGGAAGTGGCCCGCGTACAACGGGCCTTTCTCTGGTATC
TCCGTAGAATACCAGAAGAGAGATCCCGATTCGATTCTTTCACACACTCTGGGATGGACG
AGATTCAGAAAGGAAAACCAGTGGATCGATCGGGCAAAGCTCGAATTTTTGTGTAAAGAG
GACAAGTTTCTTGTGTACAGACTCTACGATGATCAGCATTCTTTGAAGGTGTTTCACAAT
CTTTCAGGGGAAGAGGTTGTCTTTGAGGGAGTTAAAATGAAGCCTTACAAAACGGAGGTG
GTTTGA

# Drug_Target_1_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_1_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
12139940	Roujeinikova A, Raasch C, Sedelnikova S, Liebl W, Rice DW: Crystal structure of Thermotoga maritima 4-alpha-glucanotransferase and its acarbose complex: implications for substrate specificity and catalysis. J Mol Biol. 2002 Aug 2;321(1):149-62.
1628664	Liebl W, Feil R, Gabelsberger J, Kellermann J, Schleifer KH: Purification and characterization of a novel thermostable 4-alpha-glucanotransferase of Thermotoga maritima cloned in Escherichia coli. Eur J Biochem. 1992 Jul 1;207(1):81-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3022

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
51844

# Drug_Target_1_Name:
4-alpha-glucanotransferase

# Drug_Target_1_Number_of_Residues:
441

# Drug_Target_1_PDB_ID:
1LWJ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF09178	DUF1945

# Drug_Target_1_Protein_Sequence:
>4-alpha-glucanotransferase
MIGYQIYVRSFRDGNLDGVGDFRGLKNAVSYLKELGIDFVWLMPVFSSISFHGYDVVDFY
SFKAEYGSEREFKEMIEAFHDSGIKVVLDLPIHHTGFLHTWFQKALKGDPHYRDYYVWAN
KETDLDERREWDGEKIWHPLEDGRFYRGLFGPFSPDLNYDNPQVFDEMKRLVLHLLDMGV
DGFRFDAAKHMRDTIEQNVRFWKYFLSDLKGIFLAEIWAEARMVDEHGRIFGYMLNFDTS
HCIKEAVWKENTRVLIESIERAVIGKDYLPVNFTSNHDMSRLASFEGGFSKEKIKLSISI
LFTLPGVPLVFYGDELGMKGVYQKPNTEVVLDPFPWNESMCVEGQTFWKWPAYNGPFSGI
SVEYQKRDPDSILSHTLGWTRFRKENQWIDRAKLEFLCKEDKFLVYRLYDDQHSLKVFHN
LSGEEVVFEGVKMKPYKTEVV

# Drug_Target_1_Reaction:
Transfers a segment of a 1,4-alpha-D-glucan to a new position in an acceptor, which may be glucose or a 1,4-alpha-D-glucan ALL_REAC (other) R05196 R06069(G)

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Transfers a segment of a 1,4-alpha-D-glucan to a new position in an acceptor, which may be glucose or a 1,4- alpha-D-glucan

# Drug_Target_1_SwissProt_ID:
P80099

# Drug_Target_1_SwissProt_Name:
MGTA_THEMA

# Drug_Target_1_Synonyms:
Amylomaltase
D-enzyme
Disproportionating enzyme
EC 2.4.1.25

# Drug_Target_1_Theoretical_pI:
5.74

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04439
